Females with Epilepsy Show Menstrual Cycle-linked Alterations in Sensory Induced Plasticity

Abstract Introduction. Catamenial epilepsy describes menstrual cycle-linked exacerbation of seizure frequency and/or intensity. To investigate its neurophysiological mechanisms, we assessed visual long-term potentiation (LTP) across the menstrual cycle using EEG and photic stimulation. Oestradiol can enhance NMDA receptor-mediated excitation and facilitate LTP, whereas allopregnanolone, a progesterone metabolite, promotes GABAergic inhibition and suppresses LTP. Methods. We recruited 28 females with epilepsy and 25 controls (mean age: 27 ± 8.52; 30 ± 7.06 years, respectively). Twenty participants with epilepsy and all controls successfully completed the visual LTP task across three menstrual phases: mid-follicular, mid-luteal, and perimenstrual. Cycle phase was verified via blood samples, and session order was counterbalanced. Standard evoked-related potential (ERP) analysis was paired with generative modelling of thalamocortical circuits. Results. In controls, P2 potentiation, a positive-going component of the ERP, was enhanced by LTP induction during the mid-follicular phase compared to the perimenstrual phase (F(2, 144) =11.54, p = 0.004 FWE-c). In contrast, females with epilepsy exhibited greater P2 potentiation during the perimenstrual and mid-luteal phases than the mid-follicular phase (F(2,228) = 11.76, p = .003 FWE-c), with only two participants showing control-like pattern of peak mid-follicular potentiation. Computational modelling indicated loss of inhibitory control and breakthrough excitability during the perimenstrual and mid-luteal phases in epilepsy. Conclusion. Our findings reveal aberrant menstrual cycle modulation of sensory-induced plasticity in epilepsy, suggesting altered inhibitory gating as well as thalamocortical excitatory drive in the mid-luteal and perimenstrual phases. While GABAergic mechanisms are often emphasised in catamenial epilepsy, our results warrant considering altered excitatory mechanisms.

Authors

Institutions

Publication Details

Journal
Neuroendocrinology
Published
2026-11-16
DOI
https://doi.org/10.1159/nen/advag017
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Females with Epilepsy Show Menstrual Cycle-linked Alterations in Sensory Induced Plasticity

Alexander D. Shaw, Malak Alshakhouri, Cynthia M. Sharpe, Khalid Hamandi et al.
1 links
Neuroendocrinology
Epilepsy research and treatment
article

Females with Epilepsy Show Menstrual Cycle-linked Alterations in Sensory Induced Plasticity

Alexander D. Shaw, Malak Alshakhouri, Cynthia M. Sharpe, Khalid Hamandi, Rachael L. Sumner, Peter Bergin
article en

Abstract

Abstract Introduction. Catamenial epilepsy describes menstrual cycle-linked exacerbation of seizure frequency and/or intensity. To investigate its neurophysiological mechanisms, we assessed visual long-term potentiation (LTP) across the menstrual cycle using EEG and photic stimulation. Oestradiol can enhance NMDA receptor-mediated excitation and facilitate LTP, whereas allopregnanolone, a progesterone metabolite, promotes GABAergic inhibition and suppresses LTP. Methods. We recruited 28 females with epilepsy and 25 controls (mean age: 27 ± 8.52; 30 ± 7.06 years, respectively). Twenty participants with epilepsy and all controls successfully completed the visual LTP task across three menstrual phases: mid-follicular, mid-luteal, and perimenstrual. Cycle phase was verified via blood samples, and session order was counterbalanced. Standard evoked-related potential (ERP) analysis was paired with generative modelling of thalamocortical circuits. Results. In controls, P2 potentiation, a positive-going component of the ERP, was enhanced by LTP induction during the mid-follicular phase compared to the perimenstrual phase (F(2, 144) =11.54, p = 0.004 FWE-c). In contrast, females with epilepsy exhibited greater P2 potentiation during the perimenstrual and mid-luteal phases than the mid-follicular phase (F(2,228) = 11.76, p = .003 FWE-c), with only two participants showing control-like pattern of peak mid-follicular potentiation. Computational modelling indicated loss of inhibitory control and breakthrough excitability during the perimenstrual and mid-luteal phases in epilepsy. Conclusion. Our findings reveal aberrant menstrual cycle modulation of sensory-induced plasticity in epilepsy, suggesting altered inhibitory gating as well as thalamocortical excitatory drive in the mid-luteal and perimenstrual phases. While GABAergic mechanisms are often emphasised in catamenial epilepsy, our results warrant considering altered excitatory mechanisms.

Neuroendocrinology
Cardiff and Vale University Health Board (GB), University of Auckland (NZ), University of Exeter (GB), Starship Children's Health (NZ), Health New Zealand (NZ), Cardiff University (GB)
Auckland Medical Research Foundation, Maurice and Phyllis Paykel Trust
Good health and well-being
Epilepsy research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon